{
  "title": "McKesson: Why the Best is Yet to Come - Ep 147",
  "itunes:title": "McKesson: Why the Best is Yet to Come - Ep 147",
  "pubDate": "Thu, 17 Feb 2022 14:00:00 +0000",
  "guid": "accbf553-1434-4231-a759-df7995bb7ffe",
  "link": "http://investor.fm/mckesson-why-the-best-is-yet-to-come-ep-147",
  "itunes:image": "",
  "description": "<p>IMA has owned McKesson stock since 2015. It has been very stressful at times, but also very rewarding. But the best is yet to come for McKesson. Vitaliy provides an update on his MCK investment, and why he believes its brightest days are ahead.</p> <p>Opioids article link: <a href= \"https://contrarianedge.com/opioids-crisis-drug-distributors/\">https://contrarianedge.com/opioids-crisis-drug-distributors/</a></p> <p>You can read this article online here: <a href= \"https://contrarianedge.com/mckesson-why-the-best-is-yet-to-come/\">https://contrarianedge.com/mckesson-why-the-best-is-yet-to-come/</a><br />  <br /> Please read the following important disclosure: <a href= \"https://contrarianedge.com/diclosure/\">https://contrarianedge.com/diclosure/</a></p> <p> </p> <p> </p>",
  "content:encoded": "<p>IMA has owned McKesson stock since 2015. It has been very stressful at times, but also very rewarding. But the best is yet to come for McKesson. Vitaliy provides an update on his MCK investment, and why he believes its brightest days are ahead.</p> <p>Opioids article link: <a href= \"https://contrarianedge.com/opioids-crisis-drug-distributors/\">https://contrarianedge.com/opioids-crisis-drug-distributors/</a></p> <p>You can read this article online here: <a href= \"https://contrarianedge.com/mckesson-why-the-best-is-yet-to-come/\">https://contrarianedge.com/mckesson-why-the-best-is-yet-to-come/</a>   Please read the following important disclosure: <a href= \"https://contrarianedge.com/diclosure/\">https://contrarianedge.com/diclosure/</a></p> <p> </p> <p> </p>",
  "enclosure": "",
  "itunes:duration": "05:59",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "IMA has owned McKesson stock since 2015. It has been very stressful at times, but also very rewarding. But the best is yet to come for McKesson. Vitaliy provides an update on his MCK investment, and why he believes its brightest days are ahead....",
  "itunes:season": 1,
  "itunes:episode": 147,
  "itunes:episodeType": "full",
  "itunes:author": "Vitaliy Katsenelson"
}